Evidence map›Paper›PMID 35112880›Full record

ArticleJournal of the American Heart Association2022

Optogenetic Control of Human Induced Pluripotent Stem Cell-Derived Cardiac Tissue Models.

Amit Gruber, Oded Edri, Shany Glatstein, Idit Goldfracht, Irit Huber, Gil Arbel, Amira Gepstein, Snizhanna Chorna, Lior Gepstein

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Guidelines for assessment of cardiac electrophysiology and arrhythmias in small animals.American journal of physiology. Heart and circulatory physiology · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Amit GruberSohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine The Rappaport Faculty of Medicine and Research InstituteTechnion‒Israel Institute of Technology Haifa Israel.ORCID 0000-0002-6366-3093
Oded EdriSohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine The Rappaport Faculty of Medicine and Research InstituteTechnion‒Israel Institute of Technology Haifa Israel.
Shany GlatsteinSohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine The Rappaport Faculty of Medicine and Research InstituteTechnion‒Israel Institute of Technology Haifa Israel.
Idit GoldfrachtSohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine The Rappaport Faculty of Medicine and Research InstituteTechnion‒Israel Institute of Technology Haifa Israel.ORCID 0000-0002-2575-2159
Irit HuberSohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine The Rappaport Faculty of Medicine and Research InstituteTechnion‒Israel Institute of Technology Haifa Israel.
Gil ArbelSohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine The Rappaport Faculty of Medicine and Research InstituteTechnion‒Israel Institute of Technology Haifa Israel.
Amira GepsteinSohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine The Rappaport Faculty of Medicine and Research InstituteTechnion‒Israel Institute of Technology Haifa Israel.
Snizhanna ChornaSohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine The Rappaport Faculty of Medicine and Research InstituteTechnion‒Israel Institute of Technology Haifa Israel.
Lior GepsteinSohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine The Rappaport Faculty of Medicine and Research InstituteTechnion‒Israel Institute of Technology Haifa Israel.ORCID 0000-0002-5351-7391
Technion – Israel Institute of Technology · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Optogenetics, using light-sensitive proteins, emerged as a unique experimental paradigm to modulate cardiac excitability. We aimed to develop high-resolution optogenetic approaches to modulate electrical activity in 2- and 3-dimensional cardiac tissue models derived from human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes. Methods and Results To establish light-controllable cardiac tissue models, opsin-carrying HEK293 cells, expressing the light-sensitive cationic-channel CoChR, were mixed with hiPSC-cardiomyocytes to generate 2-dimensional hiPSC-derived cardiac cell-sheets or 3-dimensional engineered heart tissues. Complex illumination patterns were designed with a high-resolution digital micro-mirror device. Optical mapping and force measurements were used to evaluate the tissues' electromechanical properties. The ability to optogenetically pace and shape the tissue's conduction properties was demonstrated by using single or multiple illumination stimulation sites, complex illumination patterns, or diffuse illumination. This allowed to establish in vitro models for optogenetic-based cardiac resynchronization therapy, where the electrical activation could be synchronized (hiPSC-derived cardiac cell-sheets and engineered heart tissue models) and contractile properties improved (engineered heart tissues). Next, reentrant activity (rotors) was induced in the hiPSC-derived cardiac cell-sheets and engineered heart tissue models through optogenetics programmed- or cross-field stimulations. Diffuse illumination protocols were then used to terminate arrhythmias, demonstrating the potential to study optogenetics cardioversion mechanisms and to identify optimal illumination parameters for arrhythmia termination. Conclusions By combining optogenetics and hiPSC technologies, light-controllable human cardiac tissue models could be established, in which tissue excitability can be modulated in a functional, reversible, and localized manner. This approach may bring a unique value for physiological/pathophysiological studies, for disease modeling, and for developing optogenetic-based cardiac pacing, resynchronization, and defibrillation approaches.

Indexed as

Induced Pluripotent Stem CellsAction PotentialsArrhythmias, CardiacHEK293 CellsHumansMyocytes, CardiacOptogeneticsarrhythmiasdefibrillationinduced pluripotent stem cellsmodelsoptical mappingoptogeneticstissue engineering

Identifiers

PMID35112880
PMCPMC9245811
OpenAlexW4210277817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.